Skip to content

Clinical trials

Phase 2 Epilepsy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Phase: Phase 2 Clear all

165 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20027
20033
20045
200510
20065
20075
20084
200912
20103
201110
20122
20134
20148
20156
201611
20177
201817
20197
20201
20216
202210
20231
20246
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed113
Terminated20
Unknown status14
Withdrawn5
Recruiting5
Active, not recruiting4
Not yet recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Pharma12
Jazz Pharmaceuticals9
Eisai Inc.7
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.7
National Institute of Neurological Disorders and Stroke (NINDS)6
Eisai Co., Ltd.5
Marinus Pharmaceuticals5
Neurocrine Biosciences5
Bial - Portela C S.A.4
GlaxoSmithKline4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy165
Seizures64
Epilepsies, Partial21
Drug Resistant Epilepsy11
Brain Diseases7
Migraine Disorders7
Tuberous Sclerosis6
Lennox Gastaut Syndrome5
Autistic Disorder4
Epilepsies, Myoclonic4

Trials

Showing 51 to 75 of 165. Each trial links to its page on Pharma Observatory.

65 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.